Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/17413| Title: | Coronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes |
| Authors: | Laisuan W. Wongsa C. Chiewchalermsri C. Thongngarm T. Rerkpattanapipat T. Iamrahong P. Ruangwattanachok C. Nanthapisal S. Sompornrattanaphan M. |
| Keywords: | coronavac immunoglobulin G inactivated vaccine adult anaphylaxis Article Burkholderia pseudomallei clinical article complement activation coronavirus disease 2019 drug hypersensitivity fatigue female fever genetic variation headache human intensive care unit middle aged mortality myalgia nose polyp petechia prick test revaccination shellfish allergy treatment outcome vaccination |
| Issue Date: | 2021 |
| Abstract: | Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited. |
| URI: | https://ir.swu.ac.th/jspui/handle/123456789/17413 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118542385&doi=10.2147%2fJAA.S333098&partnerID=40&md5=ea53204c87f5a790f324985731619e81 |
| ISSN: | 11786965 |
| Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.